User login
Key clinical point: Laparoscopic proximal gastrectomy (LPG) and laparoscopic total gastrectomy (LTG) lead to similar long-term outcomes and postoperative complications in patients with upper third clinical stage I gastric cancer.
Major finding: Patients who underwent LPG and LTG showed no significant difference in the 3-year overall survival (92.6% and 92.3%, respectively; P = .74), recurrence-free survival (both 85.3%; P = .72), early complication (eg, surgical site infection; P = .31), and late complication (eg, anastomotic stenosis; P = .31) rates.
Study details: This retrospective study propensity score-matched patients with upper third clinical stage I gastric cancer who underwent LTG (n = 28) and those who underwent LPG (n = 28).
Disclosures: No source of funding was reported. The authors declared no conflicts of interest.
Source: Yamamoto M et al. Laparoscopic proximal gastrectomy with novel valvuloplastic esophagogastrostomy vs laparoscopic total gastrectomy for stage I gastric cancer: A propensity score matching analysis. J Gastrointest Surg. 2022 (Aug 29). Doi: 10.1007/s11605-022-05404-y
Key clinical point: Laparoscopic proximal gastrectomy (LPG) and laparoscopic total gastrectomy (LTG) lead to similar long-term outcomes and postoperative complications in patients with upper third clinical stage I gastric cancer.
Major finding: Patients who underwent LPG and LTG showed no significant difference in the 3-year overall survival (92.6% and 92.3%, respectively; P = .74), recurrence-free survival (both 85.3%; P = .72), early complication (eg, surgical site infection; P = .31), and late complication (eg, anastomotic stenosis; P = .31) rates.
Study details: This retrospective study propensity score-matched patients with upper third clinical stage I gastric cancer who underwent LTG (n = 28) and those who underwent LPG (n = 28).
Disclosures: No source of funding was reported. The authors declared no conflicts of interest.
Source: Yamamoto M et al. Laparoscopic proximal gastrectomy with novel valvuloplastic esophagogastrostomy vs laparoscopic total gastrectomy for stage I gastric cancer: A propensity score matching analysis. J Gastrointest Surg. 2022 (Aug 29). Doi: 10.1007/s11605-022-05404-y
Key clinical point: Laparoscopic proximal gastrectomy (LPG) and laparoscopic total gastrectomy (LTG) lead to similar long-term outcomes and postoperative complications in patients with upper third clinical stage I gastric cancer.
Major finding: Patients who underwent LPG and LTG showed no significant difference in the 3-year overall survival (92.6% and 92.3%, respectively; P = .74), recurrence-free survival (both 85.3%; P = .72), early complication (eg, surgical site infection; P = .31), and late complication (eg, anastomotic stenosis; P = .31) rates.
Study details: This retrospective study propensity score-matched patients with upper third clinical stage I gastric cancer who underwent LTG (n = 28) and those who underwent LPG (n = 28).
Disclosures: No source of funding was reported. The authors declared no conflicts of interest.
Source: Yamamoto M et al. Laparoscopic proximal gastrectomy with novel valvuloplastic esophagogastrostomy vs laparoscopic total gastrectomy for stage I gastric cancer: A propensity score matching analysis. J Gastrointest Surg. 2022 (Aug 29). Doi: 10.1007/s11605-022-05404-y